Insiders · Profile

Winslow Garrett

General Counsel at Damora Therapeutics. Filing since 23 Jun 2021. CIK 0001803773

Company

Date

Role

Action

Shares

Amount

Of holding

DMRA Damora Therapeutics, Inc.

6 Jul 2026

General Counsel

Sold at will

245

$7.35K

9.7%

DMRA Damora Therapeutics, Inc.

2 Jan 2026

General Counsel

Sold at will

255

$5.45K

12.1%

DMRA Damora Therapeutics, Inc.

3 Jul 2025

General Counsel

Sold at will

260

$881.40

15.4%

DMRA Damora Therapeutics, Inc.

3 Jan 2025

General Counsel

Sold at will

471

$2.64K

31.8%

DMRA Damora Therapeutics, Inc.

3 Dec 2021

General Counsel

Bought

2,000

$4.96K

100%

DMRA Damora Therapeutics, Inc.

23 Jun 2021

General Counsel

Bought

2,000

$9.60K

opened

6 decisions on file.